136 related articles for article (PubMed ID: 8129764)
1. Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.
Polisson RP; Dooley MA; Dawson DV; Pisetsky DS
Arthritis Rheum; 1994 Jan; 37(1):50-6. PubMed ID: 8129764
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.
Salaffi F; Carotti M; Cervini C
Clin Rheumatol; 1995 Jul; 14(4):458-63. PubMed ID: 7586985
[TBL] [Abstract][Full Text] [Related]
4. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
[TBL] [Abstract][Full Text] [Related]
6. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.
Kuuliala A; Leirisalo-Repo M; Möttönen T; Hannonen P; Nissilä M; Kautiainen H; Korpela M; Julkunen H; Hakola M; Repo H;
Clin Exp Rheumatol; 2005; 23(2):243-6. PubMed ID: 15895898
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.
Suenaga Y; Yasuda M; Yamamoto M; Nonaka S; Wada T; Shiokawa S; Nobunaga M
Clin Rheumatol; 1998; 17(4):311-7. PubMed ID: 9776115
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
11. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
Crilly A; McInness IB; McDonald AG; Watson J; Capell HA; Madhok R
J Rheumatol; 1995 Feb; 22(2):224-6. PubMed ID: 7738942
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
Matsumoto T; Iwasaki K
Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment.
Boiardi L; Macchioni P; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
Clin Exp Rheumatol; 1994; 12(4):357-62. PubMed ID: 7955597
[TBL] [Abstract][Full Text] [Related]
16. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
Herzog C; Herzog A; Aeschlimann A; Gerber H; Müller W
Z Rheumatol; 1990; 49(1):8-10. PubMed ID: 2327181
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
18. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
19. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
20. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]